Benitec Biopharma Inc.

Benitec Biopharma Inc.

Biotechnology Healthcare Hayward, CA, United States BNTC (NCM)

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has Benitec Biopharma Inc. had layoffs?
No layoff events have been recorded for Benitec Biopharma Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Benitec Biopharma Inc. have?
Benitec Biopharma Inc. has approximately 19 employees.
What industry is Benitec Biopharma Inc. in?
Benitec Biopharma Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Benitec Biopharma Inc. a publicly traded company?
Yes, Benitec Biopharma Inc. is publicly traded under the ticker symbol BNTC on the NCM. The company has a market capitalization of approximately $0.44 billion.
Where is Benitec Biopharma Inc. headquartered?
Benitec Biopharma Inc. is headquartered in Hayward, CA, United States at 3940 Trust Way, Hayward, CA 94545, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.